Shankland S J, Scholey J W, Ly H, Thai K
Department of Medicine, University of Toronto, Ontario, Canada.
Kidney Int. 1994 Aug;46(2):430-42. doi: 10.1038/ki.1994.291.
Experimental type I diabetes mellitus is characterized by an early increase in kidney weight and glomerular volume, but changes in gene expression accompanying diabetic renal growth have not been fully elucidated. In the current study, total RNA was extracted from renal cortex and isolated glomeruli of streptozotocin-induced diabetic rats 24 hours, 48 hours, 96 hours, one and two weeks after the onset of hyperglycemia (blood glucose > 15 mmol/liter), insulin-treated diabetic rats (blood glucose < 6.0 mmol/liter), and normal rats. RNA samples were reverse transcribed (RT) and subjected to polymerase chain reaction (PCR) amplication with specific 5' and 3' primers for rat transforming growth factor (TGF-beta 1) and beta-actin. RT-PCR analysis revealed that glomerular TGF-beta 1 mRNA levels increased relative to beta-actin as early as 24 hours after the onset of hyperglycemia, reaching a plateau after 96 hours that was sustained at one and two weeks. In cortical samples, TGF-beta 1 mRNA levels increased less abruptly, reaching a peak one week after the onset of hyperglycemia. Intensive insulin treatment to normalize blood glucose levels attenuated the rise in glomerular and renal cortical TGF-beta 1 mRNA. Cryostat sections of rat kidneys were immunostained for TGF-beta 1 utilizing a polyclonal anti-porcine TGF-beta 1 antibody and semiquantitative scoring of TGF-beta 1 immunostaining revealed a twofold increase in diabetic glomeruli after two weeks compared to normal glomeruli. Increased segmental immunostaining for TGF-beta 1 was also evident in cortical tubules of diabetic rats. These studies establish that TGF-beta 1 expression in the kidney increases during the phase of rapid renal hypertrophy in diabetic rats. Normalization of blood glucose levels with insulin treatment attenuates the increase in TGF-beta 1 expression.
实验性I型糖尿病的特征是肾脏重量和肾小球体积早期增加,但糖尿病肾脏生长过程中伴随的基因表达变化尚未完全阐明。在本研究中,从链脲佐菌素诱导的糖尿病大鼠的肾皮质和分离的肾小球中提取总RNA,这些大鼠在高血糖发作(血糖>15 mmol/升)后24小时、48小时、96小时、1周和2周,胰岛素治疗的糖尿病大鼠(血糖<6.0 mmol/升)以及正常大鼠。RNA样本进行逆转录(RT),并用大鼠转化生长因子(TGF-β1)和β-肌动蛋白的特异性5'和3'引物进行聚合酶链反应(PCR)扩增。RT-PCR分析显示,早在高血糖发作后24小时,相对于β-肌动蛋白,肾小球TGF-β1 mRNA水平就升高,96小时后达到平台期,并在1周和2周时维持。在皮质样本中,TGF-β1 mRNA水平升高较不突然,在高血糖发作后1周达到峰值。强化胰岛素治疗使血糖水平正常化可减弱肾小球和肾皮质TGF-β1 mRNA的升高。利用多克隆抗猪TGF-β1抗体对大鼠肾脏的冰冻切片进行TGF-β1免疫染色,TGF-β1免疫染色的半定量评分显示,与正常肾小球相比,糖尿病肾小球在2周后增加了两倍。糖尿病大鼠皮质小管中TGF-β1的节段性免疫染色增加也很明显。这些研究表明,在糖尿病大鼠快速肾脏肥大阶段,肾脏中TGF-β1的表达增加。胰岛素治疗使血糖水平正常化可减弱TGF-β1表达的增加。